» Articles » PMID: 20050660

Replacing Mn(2+) with Co(2+) in Human Arginase I Enhances Cytotoxicity Toward L-arginine Auxotrophic Cancer Cell Lines

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2010 Jan 7
PMID 20050660
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Replacing the two Mn(2+) ions normally present in human Arginase I with Co(2+) resulted in a significantly lowered K(M) value without a concomitant reduction in k(cat). In addition, the pH dependence of the reaction was shifted from a pK(a) of 8.5 to a pK(a) of 7.5. The combination of these effects led to a 10-fold increase in overall catalytic activity (k(cat)/K(M)) at pH 7.4, close to the pH of human serum. Just as important for therapeutic applications, Co(2+) substitution lead to significantly increased serum stability of the enzyme. Our data can be explained by direct coordination of l-Arg to one of the Co(2+) ions during reaction, consistent with previously reported model studies. In vitro cytotoxicity experiments verified that the Co(2+)-substituted human Arg I displays an approximately 12- to 15-fold lower IC(50) value for the killing of human hepatocellular carcinoma and melanoma cell lines and thus constitutes a promising new candidate for the treatment of l-Arg auxotrophic tumors.

Citing Articles

Human 3D Lung Cancer Tissue Photothermal Therapy Using Zn- and Co-Doped Magnetite Nanoparticles.

de Moraes E, Siqueira Furtuoso Rodrigues M, de Menezes R, Vinicius-Araujo M, Valadares M, Bakuzis A ACS Biomater Sci Eng. 2025; 11(2):1084-1095.

PMID: 39853243 PMC: 11815621. DOI: 10.1021/acsbiomaterials.4c01901.


Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature.

Yuxiao C, Jiachen W, Yanjie L, Shenglan L, Yuji W, Wenbin L Front Pharmacol. 2024; 15:1446725.

PMID: 39239650 PMC: 11375294. DOI: 10.3389/fphar.2024.1446725.


Broad-spectrum anti-cancer activity of fused human arginase variants.

Prasad Y, Anakha J, Jawalekar S, Pande A Invest New Drugs. 2024; 42(5):531-537.

PMID: 39160429 DOI: 10.1007/s10637-024-01466-8.


Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial.

Russo R, Gasperini S, Bubb G, Neuman L, Sloan L, Diaz G EClinicalMedicine. 2024; 68:102405.

PMID: 38292042 PMC: 10825663. DOI: 10.1016/j.eclinm.2023.102405.


Development and characterization of fused human arginase I for cancer therapy.

Jawalekar S, Kawathe P, Sharma N, Anakha J, Tikoo K, Pande A Invest New Drugs. 2023; 41(5):652-663.

PMID: 37532976 DOI: 10.1007/s10637-023-01387-y.


References
1.
BEALE R, Croft D . A sensitive method for the colorimetric determination of urea. J Clin Pathol. 1961; 14:418-24. PMC: 480247. DOI: 10.1136/jcp.14.4.418. View

2.
Knipp M, Vasak M . A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. Anal Biochem. 2000; 286(2):257-64. DOI: 10.1006/abio.2000.4805. View

3.
Bewley M, Jeffrey P, Patchett M, Kanyo Z, Baker E . Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily. Structure. 1999; 7(4):435-48. DOI: 10.1016/s0969-2126(99)80056-2. View

4.
Periyannan G, Costello A, Tierney D, Yang K, Bennett B, Crowder M . Sequential binding of cobalt(II) to metallo-beta-lactamase CcrA. Biochemistry. 2006; 45(4):1313-20. DOI: 10.1021/bi051105n. View

5.
Auld D, Vallee B . Kinetics of carboxypeptidase A. The pH dependence of tripeptide hydrolysis catalyzed by zinc, cobalt, and manganese enzymes. Biochemistry. 1970; 9(22):4352-9. DOI: 10.1021/bi00824a016. View